Accutane Ruling Shows Experts' Power To Shape Mass Torts

Law360, New York (February 23, 2015, 9:44 PM EST) -- A New Jersey state judge's decision to reject the testimony of two plaintiffs-side expert witnesses in the long-running consolidated action over Hoffmann-La Roche Ltd.'s acne medication Accutane came after unusually long and vigorously argued Daubert-style hearings that reflect the increasing potential lately for the admission of expert testimony to make or break product liability mass torts, attorneys say.

New Jersey Superior Court Judge Nelson Johnson on Monday granted Roche's bid to reject the testimony of plaintiff experts who had linked Accutane to Crohn's disease, a variant of inflammatory bowel disease that was the subject of thousands of suits in the state...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS